200 related articles for article (PubMed ID: 38218994)
1. Synthesis of mono Cytochrome P450 in a modified CHO-CPR cell-free protein production platform.
Knauer JF; Schulz C; Zemella A; Wüstenhagen DA; Walter RM; Küpper JH; Kubick S
Sci Rep; 2024 Jan; 14(1):1271. PubMed ID: 38218994
[TBL] [Abstract][Full Text] [Related]
2. Stable Chinese Hamster Ovary Suspension Cell Lines Harboring Recombinant Human Cytochrome P450 Oxidoreductase and Human Cytochrome P450 Monooxygenases as Platform for In Vitro Biotransformation Studies.
Schulz C; Herzog N; Kubick S; Jung F; Küpper JH
Cells; 2023 Aug; 12(17):. PubMed ID: 37681872
[TBL] [Abstract][Full Text] [Related]
3. Production of reactive oxygen species by microsomes enriched in specific human cytochrome P450 enzymes.
Puntarulo S; Cederbaum AI
Free Radic Biol Med; 1998 May; 24(7-8):1324-30. PubMed ID: 9626590
[TBL] [Abstract][Full Text] [Related]
4. Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.
Venkatakrishnan K; von Moltke LL; Court MH; Harmatz JS; Crespi CL; Greenblatt DJ
Drug Metab Dispos; 2000 Dec; 28(12):1493-504. PubMed ID: 11095589
[TBL] [Abstract][Full Text] [Related]
5. Distinct effects of form selective cytochrome P450 inhibitors on cytochrome P450-mediated monooxygenase and hydrogen peroxide generating NADPH oxidase.
Mishin V; Heck DE; Jan YH; Richardson JR; Laskin JD
Toxicol Appl Pharmacol; 2022 Nov; 455():116258. PubMed ID: 36174671
[TBL] [Abstract][Full Text] [Related]
6. Ferrous and ferric state of cytochromes P450 in intact Escherichia coli cells: a possible role of cytochrome P450-flavodoxin interactions.
Culka M; Milichovsky J; Jerabek P; Stiborova M; Martinek V
Neuro Endocrinol Lett; 2015; 36 Suppl 1():29-37. PubMed ID: 26757119
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
[TBL] [Abstract][Full Text] [Related]
8. Human cytochrome P450 expression in bacteria: Whole-cell high-throughput activity assay for CYP1A2, 2A6 and 3A4.
Esteves F; Campelo D; Urban P; Bozonnet S; Lautier T; Rueff J; Truan G; Kranendonk M
Biochem Pharmacol; 2018 Dec; 158():134-140. PubMed ID: 30308189
[TBL] [Abstract][Full Text] [Related]
9. Probing the Role of the Hinge Segment of Cytochrome P450 Oxidoreductase in the Interaction with Cytochrome P450.
Campelo D; Esteves F; Brito Palma B; Costa Gomes B; Rueff J; Lautier T; Urban P; Truan G; Kranendonk M
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563285
[TBL] [Abstract][Full Text] [Related]
10. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cytochrome P450 enzymes involved in ketamine metabolism by use of liver microsomes and specific cytochrome P450 enzymes from horses, dogs, and humans.
Mössner LD; Schmitz A; Theurillat R; Thormann W; Mevissen M
Am J Vet Res; 2011 Nov; 72(11):1505-13. PubMed ID: 22023129
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of cytochrome P450 isoenzyme activity in sheep liver and placental microsomes.
Meakin AS; Amirmostofian M; Darby JR; Holman SL; Morrison JL; Wiese MD
Placenta; 2023 Jan; 131():82-89. PubMed ID: 36527743
[TBL] [Abstract][Full Text] [Related]
13. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 - similarity between human and rat enzymes.
Mizerovska J; Dracinska H; Arlt VM; Schmeiser HH; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():52-9. PubMed ID: 20027145
[TBL] [Abstract][Full Text] [Related]
14. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.
Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S
Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269
[TBL] [Abstract][Full Text] [Related]
15. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of astaxanthin, β-cryptoxanthin, canthaxanthin, lutein, and zeaxanthin on cytochrome P450 enzyme activities.
Zheng YF; Bae SH; Kwon MJ; Park JB; Choi HD; Shin WG; Bae SK
Food Chem Toxicol; 2013 Sep; 59():78-85. PubMed ID: 23669408
[TBL] [Abstract][Full Text] [Related]
17. An electron transfer competent structural ensemble of membrane-bound cytochrome P450 1A1 and cytochrome P450 oxidoreductase.
Mukherjee G; Nandekar PP; Wade RC
Commun Biol; 2021 Jan; 4(1):55. PubMed ID: 33420418
[TBL] [Abstract][Full Text] [Related]
18. Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes.
Nebot N; Crettol S; d'Esposito F; Tattam B; Hibbs DE; Murray M
Br J Pharmacol; 2010 Nov; 161(5):1059-69. PubMed ID: 20977456
[TBL] [Abstract][Full Text] [Related]
19. Herb-drug interaction between Styrax and warfarin: Molecular basis and mechanism.
Zhang F; Huang J; He RJ; Wang L; Huo PC; Guan XQ; Fang SQ; Xiang YW; Jia SN; Ge GB
Phytomedicine; 2020 Oct; 77():153287. PubMed ID: 32739573
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of phase-1 biotransformation and cytostatic effects of diphenyleneiodonium on hepatoblastoma cell line HepG2 and a CYP3A4-overexpressing HepG2 cell clone.
Schulz C; Jung F; Küpper JH
Clin Hemorheol Microcirc; 2021; 79(1):231-243. PubMed ID: 34487034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
